Open Access Green as soon as Postprint is submitted to ZB.
Imaging systemic inflammatory networks in ischemic heart disease.
J. Am. Coll. Cardiol. 65, 1583-1591 (2015)
While acute myocardial infarction mortality declines, patients continue to face reinfarction and/or heart failure. The immune system, which intimately interacts with healthy and diseased tissues through resident and recruited leukocytes, is a central interface for a global host response to ischemia. Pathways that enhance the systemic leukocyte supply may be potential therapeutic targets. Pre-clinically, imaging helps to identify immunity's decision nodes, which may serve as such targets. In translating the rapidly-expanding pre-clinical data on immune activity, the difficulty of obtaining multiple clinical tissue samples from involved organs is an obstacle that whole-body imaging can help overcome. In patients, molecular and cellular imaging can be integrated with blood-based diagnostics to assess the translatability of discoveries, including the activation of hematopoietic tissues after myocardial infarction, and serve as an endpoint in clinical trials. In this review, we discuss these concepts while focusing on imaging immune activity in organs involved in ischemic heart disease.
Altmetric
Additional Metrics?
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Review
Keywords
Atherosclerosis ; Heart Failure ; Hematopoiesis ; Leukocytes ; Myocardial Infarction ; Spleen; Acute Myocardial-infarction; Iron-oxide Nanoparticles; In-vivo; Monocyte Subsets; Atherosclerotic Lesions; Ly-6c(high) Monocytes; Arterial Inflammation; Cardiovascular Events; Progenitor Cells; Dendritic Cells
ISSN (print) / ISBN
0735-1097
e-ISSN
1558-3597
Quellenangaben
Volume: 65,
Issue: 15,
Pages: 1583-1591
Publisher
Elsevier
Publishing Place
New York, NY
Non-patent literature
Publications
Reviewing status
Peer reviewed
Institute(s)
Institute of Biological and Medical Imaging (IBMI)